VeriMomhuman neonatal fibroblast/keratinocyte conditioned media est-il sûr pendant la grossesse ?
No harmonised CLP classification, no CIR or SCCS safety assessment, and no peer‑reviewed reproductive or developmental toxicity data specifically implicating human neonatal fibroblast/keratinocyte conditioned media. The material is a complex mixture of native human proteins/growth factors; large proteins have low dermal bioavailability, so topical exposure is expected to be negligible. (Sources consulted: ECHA Annex VI (no entry), CIR (no assessment), PubMed (no reproductive toxicity reports)).
Related ingredients
Frequently asked questions
- human neonatal fibroblast/keratinocyte conditioned media est-il sûr pendant la grossesse ?
- No harmonised CLP classification, no CIR or SCCS safety assessment, and no peer‑reviewed reproductive or developmental toxicity data specifically implicating human neonatal fibroblast/keratinocyte conditioned media. The material is a complex mixture of native human proteins/growth factors; large proteins have low dermal bioavailability, so topical exposure is expected to be negligible. (Sources consulted: ECHA Annex VI (no entry), CIR (no assessment), PubMed (no reproductive toxicity reports)).
- human neonatal fibroblast/keratinocyte conditioned media est-il sûr pendant l'allaitement ?
- No evidence of reproductive or lactation-specific hazard in authoritative sources. Proteins in conditioned media are unlikely to be systemically absorbed in relevant amounts after topical use; therefore breast milk exposure is expected to be negligible absent systemic uptake. (Sources: CIR, PubMed, ECHA Annex VI — no classifications or assessments found).
- human neonatal fibroblast/keratinocyte conditioned media est-il sûr pour la peau de bébé ?
- No data indicating reproductive/developmental hazard for infants. Mechanistic concerns are theoretical only and not supported by data. Because infant skin (0–3 yr) has an immature barrier and higher surface‑area‑to‑weight, a small increase in potential exposure is prudent (adult exposure judged negligible → baby exposure scored +1). No infant‑specific absorption or toxicity studies were identified. (Sources: PubMed (no infant toxicology data), ECHA Annex VI (no entry), CIR (no assessment)).
- Comment VeriMom évalue-t-il human neonatal fibroblast/keratinocyte conditioned media ?
- VeriMom évalue human neonatal fibroblast/keratinocyte conditioned media à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à human neonatal fibroblast/keratinocyte conditioned media pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à human neonatal fibroblast/keratinocyte conditioned media basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.